According to Aerie Pharmaceuticals's latest financial reports the company has $0.17 B in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Company | Cash on Hand | differencediff. | Country |
---|---|---|---|
Merck MRK | $7.09 B | 4,012.74% | ๐บ๐ธ USA |
Lexicon Pharmaceuticals
LXRX | $0.17 B | -1.41% | ๐บ๐ธ USA |
Insmed INSM | $0.78 B | 352.53% | ๐บ๐ธ USA |